Literature DB >> 9926890

The Misgav Ladach method for cesarean section compared to the Pfannenstiel method.

E Darj1, M L Nordström.   

Abstract

OBJECTIVE: The aim of the study was to evaluate the outcome of two different methods of cesarean section (CS).
DESIGN: The study was designed as a prospective, randomized, controlled trial.
SETTING: All CS were performed at the University Hospital in Uppsala, Sweden. POPULATION: Fifty women admitted to hospital for a first elective CS were consecutively included in the study. They were randomly allocated to two groups.
METHODS: One group was operated on by the Misgav Ladach method for CS and the other group by the Pfannenstiel method. All operations were performed by the same surgeon. MAIN OUTCOME MEASURES: Duration of operation, amount of bleeding, analgesics required, scar appearance and length of hospitalization.
RESULTS: Operating time was significantly different between the two methods, with an average of 12.5 minutes with the Misgav Ladach method and 26 minutes with the Pfannenstiel method (p<0.001). The amount of blood loss differed significantly, with 448 ml and 608 ml respectively (p=0.017). Significantly less analgesic injections and tablets (p=0.004) were needed after the Misgav Ladach method.
CONCLUSION: The Misgav Ladach method of CS has advantages over the Pfannenstiel method by being significantly quicker to perform, with a reduced amount of bleeding and diminished postoperative pain. The women were satisfied with the appearance of their scars. In this study no negative effects of the new operation technique were discovered.

Entities:  

Mesh:

Year:  1999        PMID: 9926890

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  11 in total

1.  Prospective, randomized, comparative study of Misgav Ladach versus traditional cesarean section at Nazareth Hospital, Kenya.

Authors:  L Ansaloni; R Brundisini; G Morino; A Kiura
Journal:  World J Surg       Date:  2001-09       Impact factor: 3.352

2.  Modified Technique of LSCS: The Misgav Ladach Method.

Authors:  Shakti Vardhan; R C Behera; S K Kathpalia; T K Bhattacharya
Journal:  Med J Armed Forces India       Date:  2011-05-30

Review 3.  Nonsteroidal anti-inflammatory drugs for wounds: pain relief or excessive scar formation?

Authors:  Wen-Hsiang Su; Ming-Huei Cheng; Wen-Ling Lee; Tsung-Shan Tsou; Wen-Hsun Chang; Chien-Sheng Chen; Peng-Hui Wang
Journal:  Mediators Inflamm       Date:  2010-07-04       Impact factor: 4.711

4.  Caesarean deliveries by Pfannenstiel versus Joel-Cohen incision: A randomised controlled trial.

Authors:  Wessam Magdy Abuelghar; Gasser El-Bishry; Lamiaa H Emam
Journal:  J Turk Ger Gynecol Assoc       Date:  2013-12-01

5.  [Anesthetic regimen for HIV positive parturients undergoing elective cesarean section].

Authors:  D H Bremerich; A Ahr; S Büchner; H Hingott; M Kaufmann; C Faul-Burbes; P Kessler
Journal:  Anaesthesist       Date:  2003-12       Impact factor: 1.041

Review 6.  Techniques for caesarean section.

Authors:  G J Hofmeyr; M Mathai; A Shah; N Novikova
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23

Review 7.  Closure versus non-closure of the peritoneum at caesarean section: short- and long-term outcomes.

Authors:  Anthony A Bamigboye; G Justus Hofmeyr
Journal:  Cochrane Database Syst Rev       Date:  2014-08-11

8.  Maternal and fetal effect of misgav ladach cesarean section in nigerian women: a randomized control study.

Authors:  Oc Ezechi; Pm Ezeobi; Cv Gab-Okafor; A Edet; Ca Nwokoro; A Akinlade
Journal:  Ann Med Health Sci Res       Date:  2013-10

9.  Caesarean section: could different transverse abdominal incision techniques influence postpartum pain and subsequent quality of life? A systematic review.

Authors:  Salvatore Gizzo; Alessandra Andrisani; Marco Noventa; Stefania Di Gangi; Michela Quaranta; Erich Cosmi; Donato D'Antona; Giovanni Battista Nardelli; Guido Ambrosini
Journal:  PLoS One       Date:  2015-02-03       Impact factor: 3.240

10.  Case Report: Pregnancy in a patient with recurrent glioblastoma.

Authors:  Birgit Flechl; Marco Ronald Hassler; Gerhard Kopetzky; Peter Balcke; Christine Kurz; Christine Marosi
Journal:  F1000Res       Date:  2013-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.